ANI Pharmaceuticals Inc (ANIP)
Pretax margin
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | 19,868 | 13,193 | -10,540 | -34,608 | -62,670 | -87,795 | -82,703 | -82,031 | -56,058 | -27,587 | -20,394 | -16,022 | -26,009 | -31,279 | -27,383 | -7,672 | 3,157 | 18,149 | 20,556 | 18,127 |
| Revenue (ttm) | US$ in thousands | 454,334 | 417,871 | 370,670 | 328,961 | 287,962 | 256,461 | 229,582 | 208,526 | 202,730 | 205,047 | 205,953 | 205,960 | 203,642 | 194,356 | 195,209 | 203,434 | 206,547 | 215,703 | 215,069 | 207,980 |
| Pretax margin | 4.37% | 3.16% | -2.84% | -10.52% | -21.76% | -34.23% | -36.02% | -39.34% | -27.65% | -13.45% | -9.90% | -7.78% | -12.77% | -16.09% | -14.03% | -3.77% | 1.53% | 8.41% | 9.56% | 8.72% |
December 31, 2023 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $19,868K ÷ $454,334K
= 4.37%
ANI Pharmaceuticals Inc has shown a fluctuating pretax margin over the past eight quarters. The Q4 2023 pretax margin of 4.08% represents an improvement compared to the previous quarter but is significantly higher than the negative margins seen earlier in the year and in the prior year. The company has gradually improved its pretax margin since the negative margins in Q2 and Q1 2023, and there has been a steady improvement compared to the same quarter in the previous year. Overall, ANI Pharmaceuticals Inc's pretax margin has shown signs of recovery and enhanced financial performance in the most recent quarter. However, it is important to continue monitoring the trend to assess the company's long-term profitability.
Peer comparison
Dec 31, 2023